49. 全身性エリテマトーデス
[臨床試験数:827,薬物数:638(DrugBank:168),標的遺伝子数:108,標的パスウェイ数:191

Searched query = "Systemic lupus erythematosus", "SLE"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
3 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00082511
(ClinicalTrials.gov)
July 200311/5/2004GL701 (Prestara™) in Women With Systemic Lupus Erythematosus Receiving Treatment With GlucocorticoidsA Multi-Center, Open-Label Study to Assess the Durability and Safety of the Prevention of Bone Loss by Treatment With GL701 (Prestara™) in Women With Systemic Lupus Erythematosus Receiving Treatment With GlucocorticoidsSystemic Lupus ErythematosusDrug: Prasterone (GL701)Genelabs TechnologiesNULLCompleted18 YearsN/AFemale114Phase 3United States;Mexico
2NCT00053560
(ClinicalTrials.gov)
December 200230/1/2003To Assess Prevention of Bone Loss in Women With Lupus Receiving Treatment With GlucocorticoidsA Randomized, Double-Blind, Multi-Center, Placebo- Controlled Study to Assess Prevention of Bone Loss by Treatment With GL701 (Prestara) in Women With Systemic Lupus Erythematosus Receiving Treatment With GlucocorticoidsLupusDrug: Prasterone (GL701)Genelabs TechnologiesNULLActive, not recruiting18 YearsN/AFemale155Phase 3United States;Mexico
3NCT00037128
(ClinicalTrials.gov)
March 199816/5/2002Study of GL701 in Men With Systemic Lupus ErythematosusSystemic Lupus ErythematosusDrug: GL701Genelabs TechnologiesNULLActive, not recruiting18 YearsN/AMale40Phase 3United States